Indications for pediatric liver transplantation

Area of Science:

• Pediatric Hepatology
• Transplantation Immunology
• Clinical Pediatrics

Background:

• End-stage liver disease (ESLD) in children necessitates liver transplantation.
• Combination immunosuppression with cyclosporine and prednisone is a common post-transplant regimen.
• Biliary atresia, inborn errors of metabolism, and postnecrotic cirrhosis are leading indications for pediatric liver transplants.

Purpose of the Study:

• To evaluate the outcomes of orthotopic liver transplantation in pediatric patients.
• To identify factors influencing survival and causes of mortality.
• To assess the impact of retransplantation on patient survival and quality of life.

Main Methods:

• Retrospective analysis of 250 pediatric patients undergoing orthotopic liver transplantation.
• Data collection on indications, immunosuppression, survival rates, causes of death, and retransplantation outcomes.
• Assessment of quality of life in surviving patients.

Main Results:

• The 5-year actuarial survival rate for the entire cohort was 69.2%.
• Infections were the most frequent cause of death, followed by liver failure and cerebrovascular accidents.
• Retransplantation survival was significantly better when performed for rejection compared to technical complications or primary graft nonfunction.
• The majority of survivors (164/173) reported good to excellent quality of life.

Conclusions:

• Orthotopic liver transplantation offers a significant survival benefit for pediatric patients with end-stage liver disease.
• Infection remains a critical challenge in post-transplant care.
• Strategic decisions regarding retransplantation significantly impact long-term survival.
• Donor availability, particularly for smaller recipients, remains a persistent challenge in pediatric liver transplantation.